These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15283938)

  • 41. Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.
    Huber J; Palacios S; Berglund L; Hänggi W; Sathanandan SM; Christau S; Helmond F
    BJOG; 2002 Aug; 109(8):886-93. PubMed ID: 12197367
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study.
    Penotti M; Farina M; Castiglioni E; Gaffuri B; Barletta L; Gabrielli L; Vignali M
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):606-11. PubMed ID: 8828422
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin-6 and flow-mediated dilatation as markers of increased vascular inflammation in women receiving hormone therapy.
    Vitale C; Cornoldi A; Gebara O; Silvestri A; Wajngarten M; Cerquetani E; Fini M; Ramires JA; Rosano GM
    Menopause; 2005; 12(5):552-8. PubMed ID: 16145309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transvaginal color Doppler sonographic assessment of uterus and ovaries in postmenopausal women: the effect of local estrogen treatment.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):222-6. PubMed ID: 16513246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of transdermal estradiol and tibolone for the treatment of oophorectomized women with deep residual endometriosis.
    Fedele L; Bianchi S; Raffaelli R; Zanconato G
    Maturitas; 1999 Aug; 32(3):189-93. PubMed ID: 10515676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thermal balloon endometrial ablation therapy induces a rise in uterine blood flow impedance: a randomized prospective color Doppler study.
    Järvelä I; Tekay A; Santala M; Jouppila P
    Ultrasound Obstet Gynecol; 2001 Jan; 17(1):65-70. PubMed ID: 11244659
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of hormone replacement therapy and tibolone on serum leptin levels in postmenopausal women.
    Lambrinoudaki IV; Christodoulakos GE; Panoulis CP; Rizos DA; Dendrinos SG; Liakakos T; Augoulea AD; Creatsas GC
    Maturitas; 2004 Jun; 48(2):107-13. PubMed ID: 15172084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angeliq versus Activelle in normotensive postmenopausal women: a prospective, randomized pilot study.
    Battaglia C; Cianciosi A; Mancini F; Persico N; Sisti G; Facchinetti F; Busacchi P
    Menopause; 2009; 16(4):803-9. PubMed ID: 19194341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Plasma levels of total cholesterol, LDL-cholesterol, and HDL-cholesterol in postmenopausal women during 12 months' oral administration of dydrogesterone or medroxyprogesterone combined with continuous transdermal supplementation of 17beta-estradiol].
    Milewicz T; Kostecka A; Rogatko I; Sztefko K; Kwiatkowska-Panek E; Radowick S; Krzysiek J
    Przegl Lek; 2007; 64(2):65-9. PubMed ID: 17892034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy.
    Penotti M; Nencioni T; Gabrielli L; Farina M; Castiglioni E; Polvani F
    Am J Obstet Gynecol; 1993 Nov; 169(5):1226-32. PubMed ID: 8238189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of brachial artery vascular responses among postmenopausal women receiving different doses of tibolone.
    Carranza-Lira S; Cirigo-Hernández B; Sandoval-Barragán MP; Ramos-León JC
    Int J Gynaecol Obstet; 2013 Jul; 122(1):75-7. PubMed ID: 23531438
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of postmenopausal bone loss using tibolone or conventional peroral or transdermal hormone replacement therapy with 17beta-estradiol and dydrogesterone.
    Lippuner K; Haenggi W; Birkhaeuser MH; Casez JP; Jaeger P
    J Bone Miner Res; 1997 May; 12(5):806-12. PubMed ID: 9144347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: a transvaginal color Doppler study.
    Botsis D; Kassanos D; Kalogirou D; Antoniou G; Karakitsos P; Zourlas PA
    Maturitas; 1997 May; 27(1):77-83. PubMed ID: 9158081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study.
    de Azevedo GD; do Prado MF; Ferriani RA; dos Reis RM; Berezowski AT; Ribeiro TF; Silva E; de Oliveira Maranhão TM; Silva de Sá MF
    Maturitas; 2004 Mar; 47(3):195-200. PubMed ID: 15036489
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular effects of simvastatin are similar to hormone replacement therapy in postmenopausal women.
    Ociepka A; Milewicz T; Kialka M; Krzyczkowska-Sendrakowska M
    Przegl Lek; 2016; 73(5):280-6. PubMed ID: 29629740
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long term effects of Tibolone on postmenopausal women with uterine myomas.
    Gregoriou O; Konidaris S; Botsis D; Papadias C; Makrakis E; Creatsas G
    Maturitas; 2001 Oct; 40(1):95-9. PubMed ID: 11684378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy.
    Cagnacci A; Arangino S; Angiolucci M; Melis GB; Facchinetti F; Malmusi S; Volpe A
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):261-6. PubMed ID: 11207642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.